D. Schteingart

发表

Defining Translational Research: Implications for Training

D. Rubio, K. Anderson, A. Báez, 2010, Academic medicine : journal of the Association of American Medical Colleges.

Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome

S. Berent, S. Gebarski, D. Schteingart, 1992, Biological Psychiatry.

Effect of insulin on motilin release in man.

A. Vinik, D. Schteingart, A. Funakoshi, 1987, The Tohoku journal of experimental medicine.

Strength training and adiposity in premenopausal women: Strong, Healthy, and Empowered study

D. Schteingart, 2008 .

Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients

D. Schteingart, 2009 .

Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapy.

Shaomeng Wang, C. Bradford, A. Narayan, 2010, Anticancer research.

Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome.

T. Giordano, M. Burdick, R. Strieter, 2001, The Journal of clinical endocrinology and metabolism.

Management of patients with adrenal cancer: recommendations of an international consensus conference.

T. Giordano, M. Korobkin, G. Hammer, 2005, Endocrine-related cancer.

A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone.

M. Fleseriu, M. Molitch, B. Biller, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Sustained remission of Cushing's disease with mitotane and pituitary irradiation.

D. Schteingart, C. I. Taylor, A. McKenzie, 1980, Annals of internal medicine.

Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing's Disease

D. Schteingart, 2009 .

Patients with Cushing's syndrome are care-intensive even in the era of laparoscopic adrenalectomy

D. Schteingart, 2010 .

Cushing's syndrome produced by a bronchial carcinoid tumor.

R. Lloyd, D. Schteingart, D. Destephano, 1984, Human pathology.

Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.

J. Wallis, R. Ribeiro, C. Rodríguez-Galindo, 2006, The Journal of clinical endocrinology and metabolism.

Reversal or continuation of hypercortisolemic effects on subregions of the hippocampus associated with treatment response in Cushing’s disease

S. Langenecker, B. Giordani, D. Gomez-Hassan, 2015 .

Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.

S. G. Rosen, H. Akil, R. Lloyd, 1986, The Journal of clinical endocrinology and metabolism.

Neuropsychological Deficits in Cushing's Syndrome

D. Schteingart, Aaron Smith, M. Starkman, 1980, The Journal of nervous and mental disease.

Treatment of Malignant Pheochromocytoma/Paraganglioma With Cyclophosphamide, Vincristine, and Dacarbazine: Recommendation From a 22-Year Follow-up of 18 Patients

D. Schteingart, 2009 .

Neuroendocrine TumorsPractice Guidelines in Oncology

M. Choti, J. Berlin, M. Dwyer, 2012 .

Role for Adrenal Venous Sampling in Primary AldosteronismYoung WF Jr, Stanson AW, Thompson GB, et al (Mayo Clinic, Rochester, Minn) Surgery 136:1227–1235, 2004§

D. Schteingart, 2006 .

NEUROENDOCRINE TUMORS

J. Olson, D. Ettinger, J. Ajani, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

A. Dobs, P. Sarma, D. Schteingart, 1993, Metabolism: clinical and experimental.

Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?

D. Schteingart, 2009 .

Cushing's Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years' Experience at the National Institutes of Health

D. Schteingart, 2006 .

Neuroendocrine tumors.

M. Choti, J. Berlin, J. Vauthey, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus.

D. Schteingart, R. Lampman, 1991, Medicine and science in sports and exercise.

Suppression of insulin secretion by protein deprivation in obesity.

D. Schteingart, A. McKenzie, H. S. Tsao, 1979, Metabolism: clinical and experimental.

Suppression of insulin secretion by protein deprivation in obesity.

D. Schteingart, A. McKenzie, H. S. Tsao, 1979, Advances in experimental medicine and biology.

A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing's syndrome.

D. Schteingart, R. I. Gregerman, J. Conn, 1963, Metabolism: clinical and experimental.

Exercise as a partial therapy for the extremely obese.

D. Schteingart, R. Lampman, M. Foss, 1986, Medicine and science in sports and exercise.

Effectiveness of phenylpropanolamine in the management of moderate obesity.

D. Schteingart, 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Aromatic hydroxylation and alkyl oxidation in metabolism of mitotane (o,p'-DDD) in humans.

J. Sinsheimer, D. Schteingart, V. Reif, 1974, Journal of pharmaceutical sciences.

Metabolic activation and binding of mitotane in adrenal cortex homogenates.

R. Counsell, J. Sinsheimer, D. Schteingart, 1995, Journal of pharmaceutical sciences.

Identification of o,p'-dichlorodiphenyl acetic acid as a urinary metabolite of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane.

J. Sinsheimer, D. Schteingart, J. Guilford, 1972, Journal of pharmaceutical sciences.

Neuroendocrine tumors.

M. Choti, J. Berlin, M. Dwyer, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Treating Adrenal Cancer

D. Schteingart, 1992 .

Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers

D. Weismann, S. Hahner, M. Quinkler, 2011 .

Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and DeformabilityNishiyama A, Yao K, Fan Y, et al (Kagawa Med Univ, Japan; Univ of Tokushima, Japan; Kawasaki Med School, Kurashiki, Japan; et al) Hypertension 45:710–716, 2005§

D. Schteingart, 2006 .

Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.

D. Swanson, M. Gross, D. Schteingart, 1981, The Journal of clinical endocrinology and metabolism.

Aldosterone status associated with insulin resistance in patients with heart failure––data from the ALOFT study

D. Schteingart, 2010 .

Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

D. Schteingart, 2009 .

Structural requirements for mitotane activity: development of analogs for treatment of adrenal cancer.

R. Counsell, J. Sinsheimer, D. Schteingart, 2012, Anticancer research.

Adjuvant mitotane therapy of adrenal cancer - use and controversy.

D. Schteingart, 2007, The New England journal of medicine.

Treatment of adrenal carcinomas.

N. Thompson, D. Schteingart, A. Motazedi, 1982, Archives of surgery.

Current Perspective in the Diagnosis and Treatment of Adrenocortical Carcinoma

D. Schteingart, 2001, Reviews in Endocrine and Metabolic Disorders.

A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin

D. Schteingart, 2011 .

CHARACTERISTICS OF THE INCREASED ADRENOCORTICAL FUNCTION OBSERVED IN MANY OBESE PATIENTS *

D. Schteingart, J. Conn, 1965, Annals of the New York Academy of Sciences.

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma

D. Schteingart, 2012 .

Drugs in the medical treatment of Cushing's syndrome

D. Schteingart, 2009, Expert opinion on emerging drugs.

Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.

G. Glazer, I. Francis, L. Fig, 1988, Annals of internal medicine.

Correlation of bedside cognitiveand neuropsychological tests inpatients with Cushing's syndrome

M. Schork, D. Schteingart, M. Starkman, 1986 .

Osteopontin stimulates invasion of NCl-h295 cells but is not associated with survival in adrenocorticol carcinoma

D. Schteingart, 2010 .

Suppression of cortisol secretion by human growth hormone.

D. Schteingart, 1980, The Journal of clinical endocrinology and metabolism.

Sleep architecture and sleep apnea in patients with Cushing's disease.

R. Tandon, D. Schteingart, M. Starkman, 1992, Sleep.

Immune regulation in cushing's syndrome: Relationship to hypothalamic-pituitary-adrenal axis hormones

D. Schteingart, Z. Kronfol, M. Starkman, 1996, Psychoneuroendocrinology.

Glucocorticoids in the prefrontal cortex enhance memory consolidation and impair working memory by a common neural mechanism

D. Schteingart, 2011 .

Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.

D. Schteingart, J. Conn, 1967, The Journal of clinical endocrinology and metabolism.

Measurement of Serum Free Cortisol Shows Discordant Responsivity to Stress and Dynamic Evaluation

D. Schteingart, 2008 .

EEG Changes and Serum Cortisol Levels in Cushing's Syndrome

R. Tucker, D. Schteingart, M. Starkman, 1978, Clinical EEG.

Adrenocortical Carcinoma in the United States: Treatment Utilization and Prognostic Factors

D. Schteingart, 2009 .

Role of unilateral adrenalectomy in bilateral primary aldosteronism: A 22-Year single center experience

D. Schteingart, 2010 .

The diagnostic value of sodium tolbutamide in hypoglycemic states.

S. Fajans, D. Schteingart, J. Conn, 1961, The Journal of clinical endocrinology and metabolism.

Drugs in the medical treatment of Cushing's syndrome – an update on mifepristone and pasireotide

D. Schteingart, 2012, Expert opinion on emerging drugs.

Management of Adrenal Cancer

D. Schteingart, Dominic F. J. Homan, 2001 .

Functional and Oncologic Outcomes of Partial Adrenalectomy for Pheochromocytoma in Patients With von Hippel-Lindau Syndrome After at Least 5Years of Followup

D. Schteingart, 2011 .

Consequences of Adrenal Venous Sampling in Primary Hyperaldosteronism and Predictors of Unilateral Adrenal Disease

D. Schteingart, 2011 .

Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway

D. Schteingart, 2008 .

Dexamethasone-Suppression Adrenal Scintigraphy in Hyperandrogenism : Concise

D. Swanson, M. Gross, D. Schteingart, 2006 .

Combination chemotherapy in advanced adrenocortical carcinoma.

C. Schade-Brittinger, A. Tabarin, W. Kenn, 2012, The New England journal of medicine.

Transcatheter Arterial Chemoembolization for Liver Metastases in Patients with Adrenocortical Carcinoma

D. Schteingart, 2011 .

Prognostic Parameters of Metastatic Adrenocortical Carcinoma

D. Schteingart, 2008 .

Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists

D. Schteingart, 2010 .

Impact of chronic hypercortisolemia on affective processing

D. Noll, S. Langenecker, J. Zubieta, 2012, Neuropharmacology.

Scintigraphic evaluation of clinically silent adrenal masses.

G. Glazer, I. Francis, B. Shapiro, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma

R. Counsell, J. Sinsheimer, G. Abrams, 2004, Cancer Chemotherapy and Pharmacology.

Synthesis of β‐3H‐mitotane for use in a rapid assay for mitotane metabolism

R. Counsell, A. Vaz, D. Schteingart, 1995 .

Adrenal proteins bound by a reactive intermediate of mitotane

R. Counsell, A. Vaz, J. Sinsheimer, 1997, Cancer Chemotherapy and Pharmacology.

Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

D. Schteingart, 2009 .

A Novel Entity of Clinically Isolated Adrenal Insufficiency Caused by a Partially Inactivating Mutation of the Gene Encoding for P450 Side Chain Cleavage Enzyme (CYP11A1)

D. Schteingart, 2012 .

Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion.

L. Douyon, D. Schteingart, 2002, Endocrinology and metabolism clinics of North America.

Segmental uniparental isodisomy (UPD) for 2p16 without clinical symptoms: implications for UPD and other genetic studies of chromosome 2

B. Haddad, D. Schteingart, C. Stratakis, 2001, Journal of medical genetics.

Management options for persistent functional tumors.

A. Barkan, W. Chandler, D. Schteingart, 2003, Neurosurgery clinics of North America.

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

G. Hammer, P. Haluska, A. Gualberto, 2010, Cancer Chemotherapy and Pharmacology.

Adrenal cortical neoplasms producing Cushing's syndrome. A clinicopathologic study

B. A. Friedman, H. Oberman, D. Schteingart, 1968, Cancer.

Management approaches to adrenal incidentalomas. A view from Ann Arbor, Michigan.

D. Schteingart, 2000, Endocrinology and metabolism clinics of North America.

Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

D. Schteingart, D. E. Schteingart, 2012 .

Functional Characterization of the Natural Human Glucocorticoid Receptor (hGR) Mutants hGRαR477H and hGRαG679S Associated with Generalized Glucocorticoid ResistanceCharmandari E, Kino T, Ichijo T, et al (National Institutes of Health, Bethesda, Md) J Clin Endocrinol Metab 91:1535–1543, 2006§

D. Schteingart, 2007 .

The Relationship of I-131 6β-lodomethyl-19-Norcholesterol (NP-59) Adrenal Cortical Uptake to Indices of Androgen Secretion in Women with Hyperandrogenism

W. Beierwaltes, D. Swanson, B. Shapiro, 1984, Clinical nuclear medicine.

The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.

W. Beierwaltes, D. Swanson, M. Gross, 1981, The Journal of clinical endocrinology and metabolism.

The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.

W. Beierwaltes, D. Swanson, M. Gross, 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Efficacy of radiocholesterol imaging of the adrenal glands in Cushing's syndrome.

W. Beierwaltes, D. Schteingart, R. Ice, 1974, Surgery, gynecology & obstetrics.

Adrenal venography.

D. Schteingart, J. Bookstein, S. Reuter, 1968, The New England journal of medicine.

Outcome of Transsphenoidal Surgery for Cushing Disease: A Single-Center Experience Over 32 Years.

A. Barkan, W. Chandler, D. Schteingart, 2016, Neurosurgery.

The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors

D. Schteingart, 2010 .

Surgical treatment of Cushing's disease.

R. Lloyd, P. Mckeever, W. Chandler, 1987, Journal of neurosurgery.

Improvement in mood and ideation associated with increase in right caudate volume.

Bruno Giordani, B. Giordani, S. Gebarski, 2007, Journal of affective disorders.

Improvement in learning associated with increase in hippocampal formation volume

B. Giordani, S. Gebarski, D. Schteingart, 2003, Biological Psychiatry.

Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.

M. Fleseriu, M. Molitch, B. Biller, 2012, The Journal of clinical endocrinology and metabolism.

Outcomes of adrenal cortical carcinoma in the United States

D. Schteingart, 2008 .

Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment

D. Schteingart, 2008 .

Secretion of ACTH and -MSH by an adrenal medullary paraganglioma.

D. Orth, D. Schteingart, J. Bookstein, 1972, The Journal of clinical endocrinology and metabolism.

18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas

D. Schteingart, 2009 .

Adrenal function and disease in pregnancy.

D. Schteingart, 1967, Clinical obstetrics and gynecology.

18F-Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients

D. Schteingart, 2010 .

Utility of PET/CT in Differentiating Benign from Malignant Adrenal Nodules in Patients with Cancer

D. Schteingart, 2009 .

Cushing's syndrome caused by an ectopic pituitary adenoma.

R. Lloyd, W. Chandler, D. Schteingart, 1987, Neurosurgery.

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease

Bruno Giordani, S. Berent, B. Giordani, 1999, Biological Psychiatry.

Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation

D. Schteingart, 2010 .

Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing

D. Schteingart, 2010 .

Characteristics of Recovery of Adrenocortical Function After Treatment for Cushing's Syndrome Due to Pituitary or Adrenal AdenomasKlose M, Jørgensen K, Kristensen LØ (Herlev Univ Hosp, Denmark) Clin Endocrinol (Oxf) 61:394–399, 2004§

D. Schteingart, 2006 .

6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess

D. Schteingart, 2010 .

Addison's Disease in Women Is a Risk Factor for an Adverse Pregnancy Outcome

D. Schteingart, 2011 .

Virilizing syndrome associated with an adrenal cortical adenoma secreting predominantly testosterone.

D. Schteingart, A. McKenzie, H. S. Tsao, 1979, The American journal of medicine.

Functional effects of DAX-1 mutations identified in patients with X-linked adrenal hypoplasia congenita

D. Schteingart, 2012 .

Elevated Cortisol Levels in Cushing’s Disease Are Associated With Cognitive Decrements

S. Berent, M. Schork, D. Schteingart, 2001, Psychosomatic medicine.

Aldosterone Contributes to Blood Pressure Variance and to Likelihood of Hypertension in Normal-Weight and Overweight African Americans

D. Schteingart, 2010 .

Modified-release hydrocortisone to provide circadian cortisol profiles

D. Schteingart, 2010 .

Global clinical response in Cushing’s syndrome patients treated with mifepristone

G. Braunstein, D. Schteingart, D. Loriaux, 2014, Clinical endocrinology.

Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.

D. Schteingart, M. Starkman, 1981, Archives of internal medicine.

Depressed Mood and Other Psychiatric Manifestations of Cushing's Syndrome: Relationship to Hormone Levels

D. Schteingart, M. Starkman, A. Schork, 1981, Psychosomatic medicine.

Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR

D. Schteingart, 2008 .

Aldosterone Induces Angiotensin Converting Enzyme Gene Expression Via a JAK2-Dependent Pathway in Rat Endothelial Cells

D. Schteingart, 2006 .

The History of Adrenocortical Carcinoma Treatment – A Medical Perspective

D. Schteingart, 2009 .

Shifted inferior frontal laterality in women with major depressive disorder is related to emotion-processing deficits

D. Noll, S. Langenecker, M. T. Ransom, 2013, Psychological Medicine.

Controversies in the management of Cushing's disease.

W. Chandler, D. Schteingart, 1986, Clinical neurosurgery.

Conventional and novel strategies in the treatment of adrenocortical cancer.

D. Schteingart, 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Aldosterone Synthase Inhibition With LCI699: A Proof-of-Concept Study in Patients With Primary Aldosteronism

D. Schteingart, 2011 .

Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.

D. Schteingart, R. Cash, J. Conn, 1966, JAMA.

EEG sleep in cushing's disease and cushing's syndrome: comparison with patients with major depressive disorder

L. Grunhaus, R. Tandon, A. Pande, 1992, Biological Psychiatry.

EEG Sleep Cushing's Disease and Syndrome: Comparison with Patients Depressive Disorder Cushing's with Major

L. Grunhaus, R. Tandon, A. Pande, 1992 .

Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers.

R. Counsell, J. Sinsheimer, D. Schteingart, 1995, Biochemical pharmacology.

Location of ectopic adrenocortical hormone‐secreting tumors causing Cushing's syndrome in the paranasal sinuses

T. Giordano, D. Schteingart, M. Starkman, 2009, Head & neck.

Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress

D. Schteingart, 2008 .

Reversible Sympathetic Overactivity in Hypertensive Patients with Primary Aldosteronism

D. Schteingart, 2011 .

Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass

D. Schteingart, 2008 .

Discordant changes in plasma ACTH and β-lipotropin/β-endorphin levels in Clshing's disease patients with depression

D. Schteingart, M. Starkman, M.Anthony Schork, 1992, Psychoneuroendocrinology.

Bone Mineral Density Is Not Significantly Reduced in Adult Patients on Low-Dose Glucocorticoid Replacement Therapy

D. Schteingart, 2012 .

Glucocorticoid-Induced Autophagy in Osteocytes

D. Schteingart, 2011 .

Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease

S. Langenecker, K. Guire, B. Giordani, 2006, Journal of the International Neuropsychological Society.

Evaluation of the Sensitivity and Specificity of 11C-Metomidate Positron Emission Tomography (PET)-CT for Lateralizing Aldosterone Secretion by Conn's Adenomas

D. Schteingart, 2012 .

Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma.

K. Maturen, G. Hammer, F. Worden, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.

D. Schteingart, H. S. Tsao, 1980, Journal of Clinical Endocrinology and Metabolism.

Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers

D. Schteingart, 2011 .

Neoplasms of the Adrenal Cortex

D. Schteingart, 2003 .

Dexamethasone-Suppressed Corticotropin-Releasing Hormone Stimulation Test for Diagnosis of Mild Hypercortisolism

D. Schteingart, 2008 .

Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment

D. Schteingart, 2008 .

Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism

D. Schteingart, 2010 .